Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)
Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)
The goal of this observational clinical trial is to compare assessment reagents with clinical diagnostic criteria in patients with membranous nephropathy. The main questions it aims to answer are:
Participants will provide approximately 4ml of blood. Researchers will compare the levels of anti-PLA2RIgG4 in patients with membranous nephropathy and patients with other renal diseases,to see if there is a significant difference.
Inclusion Criteria:
PLA2R-induced membranous nephropathy group
Secondary membranous nephropathy group Patients in nephrology department who have ruled out primary membranous nephropathy.
the patient has the remaining serum samples of normal test, and the serum volume of the sample is not less than 1ml.
Exclusion Criteria: